Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Chemokine CXCR4 receptor antagonist shows promise in resistant/refractory AML

May 31, 2012

Celsion completes enrollment in pivotal HEAT study

May 31, 2012

Soricimed Biopharma clear to commence phase I trial of novel anticancer agent

May 31, 2012

Marshall Edwards updates on phase I study of anticancer candidate

May 31, 2012

Advaxis completes enrollment in ADXS-HPV study

May 30, 2012

BMS forms international immuno-oncology collaboration with academic institutions

May 30, 2012

ValiRx reports preclinical data on VAL-201

May 30, 2012

Oncos Therapeutics begins phase I study of oncolytic adenovirus

May 30, 2012

ImmunoGen reports novel antibodies and immunoconjugates

May 30, 2012

New clinical results presented on Ad3-hTERT-E1A

May 30, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...